Compounded GLP-1 Vial Labels: What mg, mL and Units Mean

A compounded GLP-1 vial label should help you identify what the pharmacy dispensed. It should not leave you solving a dosing puzzle. If the vial, prescription directions and supplied syringe do not make sense together, pause and ask the dispensing pharmacist to reconcile them before using the medication.

This guide explains label vocabulary and questions to ask. It deliberately contains no dose conversions, syringe measurements or injection instructions. Sources were checked October 6, 2026; this is source-based editorial guidance, not a pharmacist's review of your prescription.

Four terms that answer different questions

Milligrams, abbreviated mg, describe the mass of a substance. Milliliters, abbreviated mL, describe a volume of liquid. A concentration expressed as mg/mL describes how much of the named ingredient is present per milliliter. The total volume printed on a vial describes its contents; it is not automatically the volume prescribed for one administration.

“Units” on a syringe do not, by themselves, identify how much semaglutide or tirzepatide is in it. The medication's concentration and the specific syringe matter. FDA has reported errors involving confusion among milligrams, milliliters and units, with some patients requiring hospitalization. Its alert also describes differing concentrations among compounded semaglutide products.¹ Knowing these words is useful for a conversation with a pharmacist. It is not a reason to perform the conversion yourself.

An illustrative label map, without dose numbers

The following is an editorial example of fields to locate across the vial, pharmacy label and accompanying paperwork. Bracketed words are placeholders, not a real prescription, a legally complete label template or directions you can use.

Patient: [your name]. Pharmacy: [dispensing pharmacy and contact details]. Prescription identifier: [Rx number]. These fields help you confirm whose medicine it is and let the pharmacy find the dispensing record. If the patient name is wrong, contact the pharmacy before proceeding.

Medication: [ingredient or ingredients]. Concentration: [strength for each ingredient, with its measurement terms]. Quantity: [total liquid volume]. These describe the dispensed product. Ask the pharmacist to point out each field on your actual packaging, especially when a label has several ingredients or more than one strength expression.

Directions: [the pharmacist-confirmed instructions for this prescription]. Supplies: [the syringe or device supplied]. Ask the pharmacist to explain how the written directions relate to those exact supplies. An online chart from a different pharmacy is not a substitute for that explanation.

Dates and handling: [beyond-use date], [storage instructions], [instructions after first puncture, if applicable], [lot or batch identifier, where provided]. Keep these with the medication. The purpose of this map is to make missing or ambiguous information visible before you need it.

Ask the pharmacy to explain the dates together

A beyond-use date, often abbreviated BUD, is a limit assigned to the compounded preparation. USP's formulation guidance describes it as the date after which that preparation must not be used; it also treats packaging and storage as part of the formulation's specifications.² It is not an invitation to keep a vial indefinitely because some liquid remains.

FDA currently advises discarding compounded GLP-1 multidose vials within 28 days after first use, even if medication remains or the compounder provides a longer period.⁴ Ask the pharmacist how to record first use and identify any earlier discard requirement. A later printed BUD does not override this warning. This is separate from the storage instructions for a branded pen.

Storage instructions deserve the same attention at every refill. Empower Pharmacy's 2026 storage update, for example, tells patients with older lots to keep following the storage directions on those vial labels. It directs product questions to clinical staff.³ That illustrates why the current label matters; it does not establish a storage rule for all compounded GLP-1 medications. If a shipment's temperature is in question, follow our warm-shipment contact checklist.

Treat a refill as a new label check

Put the new packaging beside the previous packaging and identify any changes for the pharmacist: ingredient names, concentration, quantity, supplies, instructions, dates or dispensing pharmacy. Do not assume the familiar number on an older instruction sheet applies to the replacement vial. Ask the pharmacy to confirm which instructions are current and to correct conflicting documents.

This is particularly useful when switching GLP-1 providers. Tell the receiving practice what you actually have, using photographs of the label through its secure channel. Describing only a number of units omits the product information it needs to check your records.

A short message that makes the question answerable

Try: “Please review my prescription and these label photos. Can you identify the ingredient strength and total volume, confirm that the enclosed supplies match my written directions, and explain the storage and discard dates? The part I do not understand is [quote the exact wording]. Please send corrected written instructions if anything conflicts.”

Attach photographs of the vial label, pharmacy directions and supply packaging. Include the prescription number and your callback details. If the answer comes from a general customer-service agent and still leaves a medication question unresolved, request the dispensing pharmacist. Keep the response with the original paperwork so you are not relying on memory later.

A readable label does not establish FDA approval

Compounded drugs are not FDA-approved. FDA does not review them for safety, effectiveness and quality before marketing in the way it reviews approved drugs.⁴ A neat label, a pharmacy logo or a longer BUD does not change that distinction.

Use compounded versus brand-name GLP-1 and our compounded semaglutide safety guide for the broader questions. For this particular vial, the useful endpoint is a pharmacist-confirmed explanation of the product and its directions. You should not have to guess your way from a label to an injection.